Lung Cancers Terminated Phase 2 Trials for Celecoxib (DB00482)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00520845Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung CancerTreatment
NCT00527982Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung CancerTreatment